Sequent Scientific Limited , a prominent player in the life sciences sector, has successfully completed its postal ballot process for a significant corporate transformation. The company's shareholders have overwhelmingly approved the proposed name change and related corporate actions through remote e-voting.

Postal Ballot Results and Shareholder Approval

The postal ballot voting concluded on December 28, 2025, with shareholders demonstrating strong support for the proposed changes. The voting results show exceptional approval rates across both resolutions:

Key Approved Resolutions

Shareholders approved two special resolutions through the postal ballot process:

Resolution 1: Change of company name from 'Sequent Scientific Limited' to 'Viyash Scientific Limited' along with consequential alterations in the Memorandum of Association and Articles of Association.

Resolution 2: Alteration of the Objects Clause of the Memorandum of Association to align with the company's strategic direction.

Voting Participation and Process

The postal ballot process witnessed significant participation from various shareholder categories:

The e-voting process was conducted through the National Securities Depository Limited (NSDL) platform, ensuring transparency and accessibility for all eligible shareholders.

Corporate Transformation Timeline

The postal ballot notice was dispatched on November 28, 2025, following the board's earlier approval of the name change proposal. The remote e-voting period commenced on November 29, 2025, and concluded on December 28, 2025. The resolutions are deemed to have been passed on the last date of remote e-voting.

Strategic Implications

This approval marks a significant milestone in Sequent Scientific's corporate evolution, as the company transitions to the 'Viyash Scientific Limited' identity. The name change reflects the company's strategic alignment with the Viyash brand and supports its positioning in the life sciences sector. The alteration of the Objects Clause provides the company with enhanced flexibility to pursue its business objectives under the new corporate structure.

Sequent Scientific , a prominent player in the life sciences sector, has initiated a postal ballot process to seek shareholder approval for the appointment of Mr. Anuj Poddar as a Non-Executive Director. This move comes as part of the company's efforts to strengthen its board with experienced professionals.

Key Details of the Appointment

• Mr. Anuj Poddar was initially appointed as an Additional Non-Executive Director on September 5, 2025.
• The company is now seeking shareholder approval to formalize his position as a Non-Executive Director.
• If approved, Mr. Poddar will serve as a nominee of The Carlyle Group on Sequent Scientific's board.

Voting Process

• The remote e-voting period will run from October 4 to November 2, 2025.
• Results of the postal ballot are expected to be announced by November 4, 2025.
• The cut-off date for voting eligibility is set at September 26, 2025.

About Anuj Poddar

Mr. Anuj Poddar brings a wealth of experience to Sequent Scientific:

• Currently serves as Managing Director and Asia Co-Head of Global Portfolio Solutions at Carlyle, a global investment firm managing $465.00 billion in assets.
• Previously held the position of Managing Director and CEO at Bajaj Electricals, where he drove significant transformation and value creation.
• Has over 13 years of experience with Viacom18 Media, playing a key role in the company's growth.
• Holds a rank in Chartered Accountancy and is an Aspen Fellow.

Board's Rationale

The Nomination and Remuneration Committee and the Board of Directors believe that Mr. Poddar's induction will bring valuable experience to Sequent Scientific, particularly in light of increasing business complexities and evolving regulatory landscapes.

Remuneration

It's noteworthy that Mr. Poddar will not receive any sitting fees or commission for his role. However, he will be entitled to reimbursement of expenses incurred on behalf of the company, in line with company policy.

Sequent Scientific's move to appoint Mr. Anuj Poddar reflects the company's commitment to enhancing its board's expertise and strategic capabilities. Shareholders will have the opportunity to vote on this appointment, potentially shaping the future direction of the company's governance and strategic initiatives.